Fundraising Fox
Inmedix
Normandy Park, US · Delaware corporation · 1 known investors
Find your way into Inmedix
Sign up to see every warm intro you have to Inmedix
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Inmedix team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Inmedix is a medical research and diagnostics company that originated as a patent holding firm for discoveries related to treatments such as using dopamine agonists for fibromyalgia, and later shifted to precision diagnostics aimed at understanding why patients respond differently to the same treatment. It operates in the healthcare and diagnostics field.
Founders & leadership
AJ
Andrew J Holman MDFounderAndrew J. Holman holds an MD and serves as CEO and co-founder of Inmedix, a company developing ECG-based heart rate variability technology for clinical applications. He is a clinical professor of medicine at the University of Washington with a background in clinical research on fibromyalgia and Parkinson's disease treatments, and leads efforts to bring point-of-care HRV assessment through FDA clearance.
AJ
Andrew J. HolmanMD
AH
Andrew Holman, M.D.Named on SEC filing
AJ
Andrew J HolmanCo-founder, MD
TS
Timothy SciarrilloCo-founder
Board
BT
Bernie TobinBoard director
KT
Kevin Tracey, M.D.Board director
SD
Steven Daly, M.S., M.B.A.Board director
RS
Ryan Sullivan, Ph.D.Board director
LH
Leroy Hood, M.D., Ph.D.Board director
Investors · 1
Reported raises · per SEC filings
Form D private placements$5.7M disclosed across 5 rounds · 2021–2025
▶$4MraisedOct 2026 · 34 investors · BiotechnologyRule 506(c)
▶$4MraisedOct 2026 · 34 investors · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- Andrew Holman, M.D.Executive Officer, Director
- Steven Daly, M.S., M.B.A.Director
- Bernie TobinDirector
- Leroy Hood, M.D., Ph.D.Director
- Kevin Tracey, M.D.Director
- Ryan Sullivan, Ph.D.Director
- Offering amount
- $5M
- Amount sold
- $4M
- Minimum investment
- $50K
- Proceeds to insiders
- $120K
- First sale
- Sep 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06c
▶$720KraisedNov 2024 · 5 investors · BiotechnologyRule 506(c)
▶$720KraisedNov 2024 · 5 investors · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- Bernie TobinDirector
- Kevin Tracey, M.D.Director
- Steven Daly, M.S., M.B.A.Director
- Ryan Sullivan, Ph.D.Director
- Leroy Hood, M.D., Ph.D.Director
- Andrew Holman, M.D.Executive Officer, Director
- Offering amount
- $3.5M
- Amount sold
- $720K
- Minimum investment
- $20K
- First sale
- Aug 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06c
▶$25KraisedApr 2023 · BiotechnologyRule 506(c)
▶$25KraisedApr 2023 · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- Leroy Hood, M.D., Ph.D.Director
- Kevin Tracey, M.D.Director
- Steven Daly, M.S., M.B.A.Director
- Andrew Holman, M.D.Executive Officer, Director
- Bernie TobinDirector
- Offering amount
- $3M
- Amount sold
- $25K
- Minimum investment
- $25K
- First sale
- Apr 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06c
▶$445KraisedMar 2022 · 6 investors · Other Health CareRule 506(b)
▶$445KraisedMar 2022 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Steven J. DalyDirector
- Andrew J HolmanExecutive Officer, Director
- Bernie TobinDirector
- Offering amount
- $3M
- Amount sold
- $445K
- First sale
- Mar 2022
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$470KraisedMar 2021 · 8 investors · Other Health CareRule 506(b)
▶$470KraisedMar 2021 · 8 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Steven DalyDirector
- Bernie TobinDirector
- Andrew J. HolmanExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $470K
- First sale
- Mar 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 4
TrimedxTrimedx is a clinical asset performance company that manages medical devices across health systems using on-site technicians, proprietary datasets, and AI-driven intelligence to optimize device reliability, reduce costs, and enhance security. It serves integrated delivery networks, regional and academic health systems, and community healthcare providers.
AugmedixAugmedix builds AI-driven documentation technology for clinicians, aiming to reduce time spent on technology so providers can focus on patient care. It serves healthcare organizations and their clinical staff.
InfraReDxInfraredx develops intravascular imaging technology that combines high-resolution structural imaging with plaque compositional analysis to inform vascular treatment decisions. The company operates in the medical device sector and is a U.S. subsidiary within Nipro Corporation's Vascular Division.
ImvaxImvax is a clinical-stage biopharmaceutical company developing personalized immunotherapies aimed at treating solid tumors, including glioblastoma. Its platform draws on autologous, cell-based approaches to target cancer.
Companies working in the same space as Inmedix.
Frequently asked questions
- What does Inmedix do?
- Inmedix is a medical research and diagnostics company that originated as a patent holding firm for discoveries related to treatments such as using dopamine agonists for fibromyalgia, and later shifted to precision diagnostics aimed at understanding why patients respond differently to the same treatment. It operates in the healthcare and diagnostics field.
- Who founded Inmedix?
- Inmedix was founded by Andrew J Holman MD, Andrew J. Holman.
- Who are Inmedix's investors?
- Inmedix's investors include Keiretsu Forum.
- How much funding has Inmedix raised?
- Inmedix has disclosed $5.7M raised across 5 rounds.
- Where is Inmedix headquartered?
- Inmedix is headquartered in Normandy Park, US.